Clinical Trial Update: Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes the Phase 2/Phase 3 evaluation of decitabine as an adjunct after allogeneic stem cell transplantation in patients with acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myelocytic Leukemia, Myelodysplastic Syndromes | Phase 2, Phase 3 | Status: UNKNOWN